Floatz logo

PROPRANOLOL

Tuberous Sclerosis

University Hospital, BordeauxSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

14 Active assets in the Tuberous Sclerosis cohort.

Asset / SponsorPhaseRating
Everolimus
Hospices Civils de Lyon
Phase 3BBB
Rapamycin
Katarzyna Kotulska
Phase 3BBB
NPC-12G
Nobelpharma
Phase 3BB
Carbamazepine
GRIN Therapeutics, Inc.
Phase 3BB
Ganaxolone
Marinus Pharmaceuticals
Phase 3BB

View all 23 →

Same molecule, other indications

PROPRANOLOL is also rated in:

migraine disorderDormant
BBB
Indicative ·
74 / 100
View asset →
esophageal varicesDormant
BBB
Indicative ·
74 / 100
View asset →
esophageal varices with bleedingDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →